76.0%
HEK293Human Protein AtlasLS174TColorectal cancerCRCCAR-T cell therapysolid tumorsCAR-T therapyCART87urokinase plasminogen activator (uPA)
…74T, SW480, T84), as well as a CD87-negative control cell line (HEK293). To further optimize CAR design, we employed a Jurkat NFAT-Luc…